Article | October 01, 2026
Regulatory
Article | September 17, 2026
FDA Seeks Input on Regulatory Framework for Generative AI-Enabled Medical Devices
Read More
Article | September 08, 2026
Can You Say It in 30 Seconds? Short-Form Video and the Limits of Promotional Compliance
Read More
Article | July 22, 2026
FDA's Anticipated Proposed Rulemaking for Direct-to-Consumer Advertising
Read More
Article | July 07, 2026
CMS Launches New Office Focused on AI, Interoperability & Digital Health
Read More
Article | June 16, 2026
FDA’s Drug Repurposing Initiative Signals a Shift in Regulatory Strategy
Read More
Article | April 13, 2026
FDA Approves New Oral GLP-1 as Scrutiny of the Market Intensifies
Read More
Article | March 24, 2026
OPDP’s 2026 Untitled Letters: Early Enforcement Trends in Prescription Drug Promotion
Read More
Article | August 22, 2023
Panel Session Recap: Navigating the M&A Waters of FDA-Regulated Companies
Read More
Article | August 07, 2023
FDA Regulatory, Compliance, and Privacy Due Diligence — Finding Your Goldilocks Zone
Read More
Article | June 21, 2023